James Ogunade MD

James Ogunade, MD, MPH, MBA, PMP, is a distinguished physician scientist currently serving as the Director of Early Clinical Development at Pfizer, where they lead the development of studies for novel therapies in various therapeutic areas. With prior experience as a Drug Safety Specialist at Mediscreen International Limited and as a Safety Scientist at UBC, Ogunade has demonstrated expertise in clinical development, pharmacovigilance, and safety surveillance. They received their Bachelor of Medicine, Bachelor of Surgery from the University of Ilorin and are pursuing advanced degrees in Public Health and Business Administration. With strong organizational and interpersonal skills, Ogunade excels in both independent and collaborative environments.